Targeted alpha therapy with the (224)Ra/(212)Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma

Osteosarcoma patients with overt metastases at primary diagnosis have a 5-year survival rate of less than 20%. TP-3 is a murine IgG2b monoclonal antibody with high affinity for an epitope residing on the p80 osteosarcoma cell surface membrane antigen. The tumor-associated antigen p80 is overexpresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Tornes, Anna Julie Kjøl, Stenberg, Vilde Yuli, Larsen, Roy Hartvig, Bruland, Øyvind Sverre, Revheim, Mona-Elisabeth, Juzeniene, Asta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727293/
https://www.ncbi.nlm.nih.gov/pubmed/36507500
http://dx.doi.org/10.3389/fmed.2022.1058863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727293/
https://www.ncbi.nlm.nih.gov/pubmed/36507500
http://dx.doi.org/10.3389/fmed.2022.1058863

Ejemplares similares